v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss [1] $ (4,873) $ (4,514)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation [1] 1,383 1,734
Amortization of acquisition related intangible assets [1] 209 329
Non-cash operating lease cost [1] 577 565
Stock-based compensation expense [1] 2,863 3,590
Deferred income taxes [1] 18 193
Provision for credit losses [1] (346) 93
Provision for inventory [1] 832 2,063
Interest income on notes receivable [1] (224) 0
Gain on sale of Parcus Medical [1] (300) 0
Changes in operating assets and liabilities:    
Accounts receivable [1] 3,034 3,624
Inventories [1] 523 (4,090)
Prepaid expenses, other current and long-term assets [1] (203) (548)
Accounts payable [1] 47 401
Operating lease liabilities [1] (569) (546)
Accrued expenses, other current and long-term liabilities [1] (3,088) (3,110)
Income taxes [1] (13) 90
Net cash provided by (used in) operating activities [1] (130) (126)
Cash flows from investing activities:    
Proceeds from sale of Parcus Medical, net [1] 4,496 0
Purchases of property and equipment [1] (2,824) (1,808)
Net cash provided by (used in) investing activities [1] 1,672 (1,808)
Cash flows from financing activities:    
Repurchases of common stock [1] (3,971) 0
Cash paid for tax withheld on vested restricted stock awards [1] (1,467) (2,296)
Proceeds from exercises of equity awards [1] 0 23
Net cash used in financing activities [1] (5,438) (2,273)
Exchange rate impact on cash [1] 108 (31)
Decrease in cash and cash equivalents [1] (3,788) (4,238)
Cash and cash equivalents at beginning of period [1] 57,159 72,867
Cash and cash equivalents at end of period [1] 53,371 68,629
Supplemental disclosure of cash flow information:    
Purchases of property and equipment included in accounts payable and accrued expenses [1] $ 502 $ 622
[1] The cash flows related to discontinued operations and held-for-use assets and liabilities have not been segregated and remain included in the major classes of assets and liabilities. Accordingly, the Consolidated Statements of Cash Flows include the results of continuing and discontinued operations. See Note 3 for selected financial information related to significant operating and investing cash flow items from discontinued operations.